Nasal sumatriptan as adjunctive therapy for idiopathic trigeminal neuralgia: Report of three cases

Headache

Volumn 49, Issue 5, 2009, Pages 768-770

  Shimohata, Keiko ^a,c   Shimohata, Takayoshi ^b   Motegi, Ryoichiro ^a   Miyashita, Kou ^a  

^a Takasaki Pain Clinic   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Adjunctive therapy; Idiopathic trigeminal neuralgia; Nasal sumatriptan

Indexed keywords

CARBAMAZEPINE; SUMATRIPTAN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIZZINESS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC DISEASE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; TRIGEMINUS NEURALGIA; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRANASAL; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NEUROGENIC INFLAMMATION; NEUROPEPTIDES; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; TRIGEMINAL NERVE; TRIGEMINAL NEURALGIA;

EID: 65449140575     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01254.x     Document Type: Article

References (12)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia. 2004 24 (Suppl. 1 9 160.
2. Nurmikko TJ, Jensen TS. Trigeminal neuralgia and other facial neuralgias. In : Olesen J, Goadsby PJ, Ramadam NM, Tfelt-Hansen P, eds. The Headaches. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 1053 1062.
3. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002 18 : 28 34. (Pubitemid 34118962)
4. Nurmikko TJ, Eldridge PR. Trigeminal neuralgia - pathophysiology, diagnosis and current treatment. Br J Anaesth. 2001 87 : 117 132. (Pubitemid 32631681)
5. Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006 46 : 577 582.
6. Bouchelet I, Cohen HB, Case B, Seguela P, Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol. 1996 50 : 219 223. (Pubitemid 26265123)
7. Limmroth V, Katsarava Z, Liedert B, et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain. 2001 92 : 101 106. (Pubitemid 32367941)
8. Strittmatter M, Grauer M, Isenberg E, et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache. 1996 37 : 211 216.
9. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 1987 403 : 350 354. (Pubitemid 17019718)
10. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002 346 : 257 270.
11. Backonja M-M. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002 59 : S14 17.
12. Pascual J. Subcutaneous sumatriptan for trigeminal neuralgia? Headache. 2006 46 : 583 584.